• On 01 October 2021, the Food and Drug Administration (FDA) issued authorization (amended on 17 November 2021) granting Roche (Philippines), Inc. the emergency use approval of Casirivimab + Imdevimab.
  
  

Product Information
 English    

• For more information on reporting side effects, click here.